Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes
- Posted on August 25, 2026
- By Google News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes
Libre Duo 10 Day is a first-of-its-kind, two-in-one biowearable that monitors glucose and helps detect rising ketone levels that can lead to diabetic...
